Skip to main content

Startups & scaleups

Startups and scaleups are driving growth in the BioRegion. In 2024 alone, they raised €347 million in investment. Since 2013, the rate of startup creation has exceeded 50 companies per year. Additionally, 24% of health sector startups in Catalonia are spin-offs from research institutions, and 31% of emerging companies are led by women.

inbrain neuroelectronics

Inbrain Neuroelectronics

A spin-off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and the Catalan Institute for Research and Advanced Studies (ICREA), which has developed an electrocorticography (μECoG) grid for intraoperative brain mapping to support brain resection surgery in patients with epilepsy or brain tumours.

Sector: Tecmed
Subsector: Medical devices
Investment secured

Investment in startups and scaleups recovers and achieves nearly €350 million

After any complication in the global geo-political and economic context in terms of investment indicators for the BioRegion in 2023, by 2024 the BioRegion has recovered its embryonic status. Així, with a figure that exceeds €347 M in investments made by Catalan startups and scaleups in 2024, has been positive news for the sector, and in fact, is in line with the record numbers of 2022.

Startups working on health AI

112 startups and scaleups are working on health AI in Catalonia this 2024

155 companies develop this transformative and strategic technology for the health sector. The majority of these companies (112) are startups and scaleups, a figure that represents an increase of 32% compared to 2023, which at the same time represent 24% of the total active startups and scaleups in the BioRegion (470). Together they have attracted 61% of the total risk capital raised.​​

Featured startups

 impress

Impress

Impress specializes in invisible orthodontics and uses the most advanced technology for diagnosing and improving oral health. They closed a €122 million round in 2022.

Sector: Tecmed
Subsector: Medical devices
Minoryx Therapeutics

Minoryx Therapeutics

Minoryx develops therapies for orphan diseases of the central nervous system. In May 2022, the company closed a €51 million Series C round and in November licensed its drug leriglitazone for X-ALD.

Sector: Biotec
Subsector: Medicines and diagnosis
 splicebio

Splice Bio

Splice Bio uses protein splicing to push the limits of adeno-associated virus (AAV) vector applications and develop gene therapies for large genes.

Sector: Biotec
Subsector: Medicines and diagnosis
neuroelectrics

Neuroelectris

A company that has developed a medical device for non-invasive electrical brain stimulation for personalised neuromodulation. This device measures and modifies brain function to restore health, minimise disability and improve patients' lives.

Sector: Tecmed
Subsector: Medical devices
HumanITCare

HumanITCare

HumanITCare has developed a telemedicine platform that allows for remote medical monitoring, provides at home care and compiles data in real time for research.

Sector: Digital health
Subsector: Digital therapies (DTx)
Mowoot

UsMIMA (MowoOt)

UsMIMA has developed a medical device (MowoOt), inspired by the abdominal massages of the Institut Guttman therapists, for chronic constipation. It is the first startup created from the d·HEALTH Barcelona program.

Sector: Tecmed
Subsector: Medical devices
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.